Nanobiotix presents early lung cancer trial data at ESTRO

research breakthrough expired 66% AI & Tech

Nanobiotix has presented early trial data for a new lung cancer treatment at the ESTRO conference, which shows promising results and could pave the way for further investments in innovative cancer therapies. This development highlights the potential of nanotechnology in medicine.

🌐 Location: Europe — Sources: 9 — First seen: — Last seen:
lung cancer trial data Nanobiotix ESTRO nanotechnology

Linked Entities

gene therapy

organization involved

AAV

organization involved

Lumentum Holdings Inc.

organization involved

Contributing Articles